References
74
Referenced
143
10.1093/hmg/10.2.107
/ Hum. Mol. Genet. / Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice by Abel (2001)10.1016/S0925-4773(99)00321-4
/ Mech. Dev. / Salivary gland development in Drosophila melanogaster by Andrew (2000)10.1128/MCB.25.4.1425-1436.2005
/ Mol. Cell. Biol. / Hey1, a mediator of notch signaling, is an androgen receptor corepressor by Belandia (2005)10.1038/emboj.2008.123
/ EMBO J. / Implementing the LIM code: the structural basis for cell type-specific assembly of LIM-homeodomain complexes by Bhati (2008)10.1242/dev.118.2.401
/ Development / Targeted gene expression as a means of altering cell fates and generating dominant phenotypes by Brand (1993)10.1210/endo.139.1.5696
/ Endocrinology / Substitution of Ala564 in the first zinc cluster of the deoxyribonucleic acid (DNA)-binding domain of the androgen receptor by Asp, Asn, or Leu exerts differential effects on DNA binding by Brüggenwirth (1998)10.1210/me.2004-0266
/ Mol. Endocrinol. / Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression by Burd (2005)10.1074/jbc.M210744200
/ J. Biol. Chem. / Dual function of an amino-terminal amphipatic helix in androgen receptor-mediated transactivation through specific and nonspecific response elements by Callewaert (2003)10.1016/j.tips.2005.03.002
/ Trends Pharmacol. Sci. / Androgen receptor-cofactor interactions as targets for new drug discovery by Chang (2005)10.1074/jbc.M506147200
/ J. Biol. Chem. / Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor by Chen (2005)10.1523/JNEUROSCI.0808-04.2004
/ J. Neurosci. / Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy by Chevalier-Larsen (2004)10.1210/me.2003-0375
/ Mol. Endocrinol. / Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor by Dubbink (2004)10.1016/S0896-6273(03)00258-7
/ Neuron / Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice by Emamian (2003)10.1038/35040584
/ Nature / Identification of genes that modify ataxin-1-induced neurodegeneration by Fernandez-Funez (2000)10.1038/nn2011
/ Nat. Neurosci. / Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration by Friedman (2007){'key': '10.1016/j.neuron.2010.08.034_bib16', 'first-page': '2112', 'article-title': 'SMAD3 represses androgen receptor-mediated transcription', 'volume': '61', 'author': 'Hayes', 'year': '2001', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / SMAD3 represses androgen receptor-mediated transcription by Hayes (2001)10.1074/jbc.274.52.37219
/ J. Biol. Chem. / Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain by He (1999)10.1074/jbc.M107492200
/ J. Biol. Chem. / Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 coactivator recruitment by activation function 2 by He (2001)10.1016/j.molcel.2004.09.036
/ Mol. Cell / Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance by He (2004)10.1210/edrv.23.2.0460
/ Endocr. Rev. / Androgen receptor (AR) coregulators: an overview by Heinlein (2002)10.1371/journal.pbio.0040067
/ PLoS Biol. / Glutamine-expanded ataxin-7 alters TFTC/STAGA recruitment and chromatin structure leading to photoreceptor dysfunction by Helmlinger (2006)10.1016/S0896-6273(00)80764-3
/ Neuron / A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration by Hodgson (1999)10.1074/jbc.M211908200
/ J. Biol. Chem. / The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs by Hsu (2003)10.1016/S0896-6273(02)00834-6
/ Neuron / Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy by Katsuno (2002)10.1126/science.287.5459.1837
/ Science / Genetic suppression of polyglutamine toxicity in Drosophila by Kazemi-Esfarjani (2000)10.1212/WNL.18.7.671
/ Neurology / Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait by Kennedy (1968)10.1038/nrg1581
/ Nat. Rev. Genet. / Nuclear receptors—a perspective from Drosophila by King-Jones (2005)10.1016/S0092-8674(00)81781-X
/ Cell / Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice by Klement (1998)10.1038/352077a0
/ Nature / Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy by La Spada (1991)10.1073/pnas.96.26.14724
/ Proc. Natl. Acad. Sci. USA / Convergence of two repressors through heterodimer formation of androgen receptor and testicular orphan receptor-4: a unique signaling pathway in the steroid receptor superfamily by Lee (1999)10.1074/jbc.M206374200
/ J. Biol. Chem. / Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT by Liao (2003)10.1038/nature06731
/ Nature / Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1 by Lim (2008)10.1210/me.2004-0117
/ Mol. Endocrinol. / Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells by Lin (2004)10.1073/pnas.0736237100
/ Proc. Natl. Acad. Sci. USA / Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions by Loy (2003)10.1016/j.modgep.2005.07.006
/ Gene Expr. Patterns / The expression pattern of the Drosophila vesicular glutamate transporter: a marker protein for motoneurons and glutamatergic centers in the brain by Mahr (2006)10.1242/dev.00933
/ Development / Caspases function in autophagic programmed cell death in Drosophila by Martin (2004)10.1073/pnas.0503493102
/ Proc. Natl. Acad. Sci. USA / Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity by McMahon (2005)10.1073/pnas.0705501104
/ Proc. Natl. Acad. Sci. USA / Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease by Monks (2007)10.1093/hmg/ddp115
/ Hum. Mol. Genet. / Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy by Montie (2009)10.1038/nn1717
/ Nat. Neurosci. / JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport by Morfini (2006)10.1101/gad.5.4.583
/ Genes Dev. / Glass encodes a site-specific DNA-binding protein that is regulated in response to positional signals in the developing Drosophila eye by Moses (1991)10.1093/emboj/19.3.359
/ EMBO J. / FHL2, a novel tissue-specific coactivator of the androgen receptor by Müller (2000)10.1021/jm020200g
/ J. Med. Chem. / Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents by Ohtsu (2002)10.1093/hmg/ddm109
/ Hum. Mol. Genet. / Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity by Palazzolo (2007)10.1073/pnas.0503505102
/ Proc. Natl. Acad. Sci. USA / Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration by Palhan (2005)10.1074/jbc.271.39.24151
/ J. Biol. Chem. / Mutual transcriptional interference between RelA and androgen receptor by Palvimo (1996)10.1038/nature05853
/ Nature / HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS by Pandey (2007)10.1006/mcne.1999.0773
/ Mol. Cell. Neurosci. / Nuclear targeting of mutant Huntingtin increases toxicity by Peters (1999)10.1210/me.2004-0065
/ Mol. Endocrinol. / The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptor by Powzaniuk (2004)10.1210/jcem.74.4.1347772
/ J. Clin. Endocrinol. Metab. / Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status by Quigley (1992)10.1523/JNEUROSCI.5894-09.2010
/ J. Neurosci. / TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97 by Ritson (2010)10.1016/S0092-8674(00)81782-1
/ Cell / Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions by Saudou (1998)10.2174/1568009023333845
/ Curr. Cancer Drug Targets / Pharmacogenomics opportunities in nuclear receptor targeted cancer therapy by Schapira (2002)10.1074/jbc.271.39.23907
/ J. Biol. Chem. / Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression by Schneikert (1996)10.1016/S0896-6273(04)00082-0
/ Neuron / Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration by Sopher (2004)10.1073/pnas.0809819106
/ Proc. Natl. Acad. Sci. USA / Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity by Suzuki (2009)10.1016/S0896-6273(03)00569-5
/ Neuron / Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport by Szebenyi (2003)10.1016/S0896-6273(02)00875-9
/ Neuron / Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila by Takeyama (2002)10.1271/bbb.68.1209
/ Biosci. Biotechnol. Biochem. / A novel genetic system for analysis of co-activators for the N-terminal transactivation function domain of the human androgen receptor by Takeyama (2004)10.1074/jbc.M506751200
/ J. Biol. Chem. / Ataxin-7 can export from the nucleus via a conserved exportin-dependent signal by Taylor (2006)10.1093/genetics/122.3.595
/ Genetics / Cloning and characterization of the scarlet gene of Drosophila melanogaster by Tearle (1989)10.1074/jbc.M311761200
/ J. Biol. Chem. / Androgen receptor acetylation site mutations cause trafficking defects, misfolding, and aggregation similar to expanded glutamine tracts by Thomas (2004)10.1093/hmg/ddl148
/ Hum. Mol. Genet. / Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy by Thomas (2006)10.1016/j.cell.2005.06.012
/ Cell / The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins by Tsuda (2005)10.1083/jcb.200609178
/ J. Cell Biol. / Compartmentalization of androgen receptor protein-protein interactions in living cells by van Royen (2007)10.1093/emboj/16.11.3145
/ EMBO J. / The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins by Wadman (1997)10.1128/MCB.24.5.2202-2213.2004
/ Mol. Cell. Biol. / Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cells by Wang (2004)10.1074/jbc.M313963200
/ J. Biol. Chem. / Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells by Wang (2004)10.1038/nm1547
/ Nat. Med. / ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor by Yang (2007)10.1073/pnas.92.15.7036
/ Proc. Natl. Acad. Sci. USA / Green fluorescent protein as a vital marker and reporter of gene expression in Drosophila by Yeh (1995)10.1006/bbrc.1998.8974
/ Biochem. Biophys. Res. Commun. / Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells by Yeh (1998)10.1128/MCB.21.14.4614-4625.2001
/ Mol. Cell. Biol. / Inhibition of androgen receptor-mediated transcription by amino-terminal enhancer of split by Yu (2001)10.1128/MCB.24.3.1044-1057.2004
/ Mol. Cell. Biol. / ARA67/PAT1 functions as a repressor to suppress androgen receptor transactivation by Zhang (2004)10.1146/annurev.neuro.23.1.217
/ Annu. Rev. Neurosci. / Glutamine repeats and neurodegeneration by Zoghbi (2000)
Dates
Type | When |
---|---|
Created | 14 years, 11 months ago (Sept. 24, 2010, 6:33 a.m.) |
Deposited | 1 year, 4 months ago (April 22, 2024, 3:24 p.m.) |
Indexed | 3 weeks ago (Aug. 5, 2025, 8:55 a.m.) |
Issued | 14 years, 11 months ago (Sept. 1, 2010) |
Published | 14 years, 11 months ago (Sept. 1, 2010) |
Published Print | 14 years, 11 months ago (Sept. 1, 2010) |
Funders
4
Kennedy's Disease Association
10.13039/100003914
Region: Americas
gov (Associations and societies (private and public))
Labels
3
- Kennedy's Disease Association, Inc.
- The Kennedy's Disease Association
- KDA
Muscular Dystrophy Association
10.13039/100005202
Region: Americas
gov (Associations and societies (private and public))
Labels
2
- Muscular Dystrophy Association, Inc.
- MDA
National Institutes of Health
10.13039/100000002
Region: Americas
gov (National government)
Labels
3
- Institutos Nacionales de la Salud
- US National Institutes of Health
- NIH
Awards
1
- NS053825
American Lebanese Syrian Associated Charities
10.13039/100012524
Region: Americas
pri (Trusts, charities, foundations (both public and private))
Labels
1
- ALSAC
@article{Nedelsky_2010, title={Native Functions of the Androgen Receptor Are Essential to Pathogenesis in a Drosophila Model of Spinobulbar Muscular Atrophy}, volume={67}, ISSN={0896-6273}, url={http://dx.doi.org/10.1016/j.neuron.2010.08.034}, DOI={10.1016/j.neuron.2010.08.034}, number={6}, journal={Neuron}, publisher={Elsevier BV}, author={Nedelsky, Natalia B. and Pennuto, Maria and Smith, Rebecca B. and Palazzolo, Isabella and Moore, Jennifer and Nie, Zhiping and Neale, Geoffrey and Taylor, J. Paul}, year={2010}, month=sep, pages={936–952} }